Drug intelligence / Profile preview

glyceryl eicosapentaenoate

Development stage: Preclinical
Administration: Topical

Overview

Glyceryl eicosapentaenoate is an ester derived from eicosapentaenoic acid (EPA), an omega-3 polyunsaturated fatty acid. It is under investigation as an ingredient in topical skincare formulations, notably creams and serums, for its potential moisturizing and hydration-enhancing effects on sensitive and dry skin. Unlike ethyl eicosapentaenoate (icosapent ethyl), glyceryl eicosapentaenoate is not approved as a pharmaceutical for systemic use and currently is studied only for topical dermatological applications.

Beyond the preview

Go deeper on glyceryl eicosapentaenoate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on glyceryl eicosapentaenoate.

Explore the full profile